---
figid: PMC4817351__nihms754618f8
figtitle: Molecular pathways of proliferation, survival and senescence
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC4817351
filename: nihms754618f8.jpg
figlink: /pmc/articles/PMC4817351/figure/F8/
number: F8
caption: Molecular pathways of proliferation, survival and senescence. Extracellular
  growth factors trigger the dimerisation of receptor tyrosine kinases, leading to
  autophosphorylation and activation of intracellular signalling cascades such as
  the MAPK/ERK or the PI3K/AKT/mTOR pathway. Among a variety of other functions, these
  signalling pathways increase cell proliferation and survival. Many of the components,
  especially of the MAPK/ERK pathway, show genetic aberrations in spitzoid melanocytic
  tumours, which lead to a constitutive pathway activation. However, the activation
  of oncogenic pathways epigenetically de-represses the CDKN2A locus, encoding the
  proteins p16 and p14. Oncogene activation and cell proliferation may also lead to
  telomere shortening and increased concentrations of reactive oxygen species (ROS),
  which causes a DNA-damage response and activates p53 and p21. The signalling cascades
  of the p16 and p53 pathway converge on the tumour suppressor retinoblastoma (Rb)
  and on cell cycle inhibitors. After initial cell proliferation, these signalling
  pathways cause a durable proliferative arrest, termed senescence.
papertitle: Genomic aberrations in spitzoid tumours and their implications for diagnosis,
  prognosis and therapy.
reftext: Thomas Wiesner, et al. Pathology. ;48(2):113-131.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9771199
figid_alias: PMC4817351__F8
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC4817351__F8
ndex: d3e6fd2e-debc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4817351__nihms754618f8.html
  '@type': Dataset
  description: Molecular pathways of proliferation, survival and senescence. Extracellular
    growth factors trigger the dimerisation of receptor tyrosine kinases, leading
    to autophosphorylation and activation of intracellular signalling cascades such
    as the MAPK/ERK or the PI3K/AKT/mTOR pathway. Among a variety of other functions,
    these signalling pathways increase cell proliferation and survival. Many of the
    components, especially of the MAPK/ERK pathway, show genetic aberrations in spitzoid
    melanocytic tumours, which lead to a constitutive pathway activation. However,
    the activation of oncogenic pathways epigenetically de-represses the CDKN2A locus,
    encoding the proteins p16 and p14. Oncogene activation and cell proliferation
    may also lead to telomere shortening and increased concentrations of reactive
    oxygen species (ROS), which causes a DNA-damage response and activates p53 and
    p21. The signalling cascades of the p16 and p53 pathway converge on the tumour
    suppressor retinoblastoma (Rb) and on cell cycle inhibitors. After initial cell
    proliferation, these signalling pathways cause a durable proliferative arrest,
    termed senescence.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ntrk1
  - Ret
  - Ros1
  - Alk
  - ras
  - Hras
  - Kras
  - Rem1
  - Cdkn2a
  - Zhx2
  - Pik3r1
  - Pten
  - Cyp2b10
  - Rbm14
  - Pcolce
  - S100a9
  - Lamtor2
  - Mdk
  - Akt1
  - Cdk6
  - Cdk4
  - Ephb2
  - Mapk1
  - Mtor
  - Mdm2
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdk2
  - Trp53
  - NTRK1
  - RET
  - ROS1
  - ALK
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - KRAS
  - HRAS
  - NRAS
  - CDKN2A
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - H3P10
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - CDK6
  - CDK4
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - MDM2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDK2
  - TP53
  - TP63
  - TP73
  - tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
